Does Medicare Cover Wegovy? Insurance Guide 2026

Weight loss and diabetes management are critical health priorities, and medications like Wegovy have emerged as powerful tools in these battles. However, navigating insurance coverage—especially Medicare—can be complex. This guide breaks down everything you need to know about Medicare’s relationship with Wegovy in 2026, from diabetes and weight loss coverage to cost-saving strategies and appeals processes.

Does Medicare Cover Wegovy for Diabetes?

Medicare does cover Wegovy (semaglutide) for beneficiaries with Type 2 diabetes under specific conditions. Since Wegovy is the same active ingredient as Ozempic—a medication approved for diabetes management—it may be prescribed off-label for glycemic control. However, coverage hinges on medical necessity. Your doctor must document that Wegovy is essential for managing blood sugar levels, especially if other treatments (like metformin or insulin) have failed.

Under Medicare Part D, Wegovy is typically included in formularies for diabetes, but prior authorization is often required. Some Part D plans may classify Wegovy as a “preferred” or “non-preferred” drug, affecting out-of-pocket costs. If prescribed for diabetes, Wegovy is more likely to be covered than when used solely for weight loss. Always verify your plan’s formulary or consult your pharmacist to confirm Wegovy’s status.

Does Medicare Cover Wegovy for Weight Loss?

Medicare does not cover Wegovy for weight loss alone. The Centers for Medicare & Medicaid Services (CMS) explicitly excludes coverage for weight loss medications under Medicare Part D, even if obesity is a diagnosed condition. This policy stems from the Medicare Modernization Act of 2003, which prohibits Part D from covering drugs used for “anorexia, weight loss, or weight gain.”

However, there are exceptions. If you have obesity-related comorbidities (e.g., Type 2 diabetes, hypertension, or cardiovascular disease), your doctor may prescribe Wegovy for its approved diabetes indication, which could indirectly aid weight loss. In such cases, Wegovy might be covered, but the primary diagnosis must align with Medicare’s rules. For pure weight loss, beneficiaries must explore alternatives like lifestyle programs or pay out-of-pocket.

How Much Does Wegovy Cost With Medicare?

The cost of Wegovy with Medicare varies widely depending on your Part D plan, formulary tier, and whether you’ve met your deductible. Without insurance, Wegovy retails for approximately $1,300–$1,600 per month. With Medicare, your out-of-pocket costs could range from $20 to $500 per month, depending on your plan’s copay structure.

Most Part D plans place Wegovy in Tier 3 (preferred brand) or Tier 4 (non-preferred brand), leading to higher copays. If your plan requires prior authorization and it’s approved, you may pay a 25% coinsurance until you reach the catastrophic coverage phase (after ~$7,400 in total drug costs in 2026). Some beneficiaries qualify for Extra Help, a low-income subsidy that reduces Wegovy costs to $0–$10 per month. Always compare plans during Open Enrollment to find the most affordable Wegovy coverage.

Wegovy Prior Authorization for Medicare

Prior authorization (PA) is a common requirement for Wegovy under Medicare Part D. Your doctor must submit clinical documentation proving Wegovy is medically necessary, whether for diabetes or an obesity-related condition. For diabetes, this includes HbA1c levels, failed responses to other medications, or hypoglycemia risks. For obesity, some plans may approve Wegovy if you have a BMI ≥ 30 (or ≥ 27 with comorbidities) and have tried diet/exercise without success.

The PA process typically takes 5–10 business days. If denied, your doctor can appeal by providing additional evidence, such as weight-related health risks (e.g., sleep apnea, joint pain). Some Medicare Advantage plans (Part C) may have stricter PA criteria, so check your plan’s guidelines. If Wegovy is denied, ask your doctor about alternative GLP-1 agonists (like Saxenda) that may have different coverage rules.

How to Get Medicare to Cover Wegovy

To maximize your chances of getting Wegovy covered by Medicare, follow these steps:

1. Confirm Medical Necessity: Ensure your doctor documents Wegovy’s necessity for diabetes management or obesity-related conditions (e.g., hypertension, heart disease). Avoid framing it solely as a weight-loss drug.

2. Check Your Formulary: Use Medicare’s Plan Finder Tool to compare Part D plans that include Wegovy in their formulary. Look for plans with lower copays or fewer restrictions.

3. Submit Prior Authorization: Work with your doctor to complete the PA form, including lab results, treatment history, and failed therapies. Some plans require step therapy (trying cheaper drugs first).

4. Appeal if Denied: If Wegovy is denied, request a redetermination (first-level appeal) within 60 days. Provide peer-reviewed studies showing Wegovy’s efficacy for your condition.

5. Explore Patient Assistance Programs: Novo Nordisk, Wegovy’s manufacturer, offers a savings card (up to $500/month) for eligible Medicare beneficiaries. Income limits apply, but it can significantly reduce costs.

What to Do If Medicare Denies Wegovy

If Medicare denies coverage for Wegovy, you have multiple appeal options:

1. Request a Redetermination: Submit a written appeal to your Part D plan within 60 days of the denial. Include a letter of support from your doctor and any new clinical evidence (e.g., recent lab results).

2. Independent Review Entity (IRE): If the redetermination fails, escalate to an IRE (second-level appeal). This involves an external reviewer who reassesses your case. The IRE must respond within 7 days for expedited requests.

3. Administrative Law Judge (ALJ) Hearing: If the IRE denies your appeal, you can request an ALJ hearing (third-level appeal). This is a formal process where you (or your representative) present your case. Wait times can exceed 90 days, but the success rate is higher at this stage.

4. Medicare Appeals Council: If the ALJ denies your claim, you can appeal to the Medicare Appeals Council (fourth level). This is a final review by CMS.

5. Federal Court: As a last resort, you can file a lawsuit in federal district court if the amount in controversy meets the minimum threshold ($1,850 in 2026).

Medicare Alternatives If Wegovy Is Not Covered

If Wegovy isn’t covered or is too expensive, consider these alternatives:

1. Other GLP-1 Agonists: Saxenda (liraglutide) is FDA-approved for weight loss and may be covered under some Part D plans. Zepbound (tirzepatide) is another option, though it’s newer and less likely to be covered.

2. Lifestyle Programs: Medicare covers intensive behavioral therapy (IBT) for obesity, including 12–22 sessions with a primary care doctor or specialist. These programs focus on diet, exercise, and counseling.

3. Bariatric Surgery: For severe obesity (BMI ≥ 35 with comorbidities), Medicare covers gastric bypass, sleeve gastrectomy, and adjustable gastric banding. Surgery is a long-term solution but requires meeting strict criteria.

4. Clinical Trials: Some Medicare beneficiaries qualify for free Wegovy through clinical trials. Check ClinicalTrials.gov for studies recruiting participants with obesity or diabetes.

5. Manufacturer Coupons: Novo Nordisk’s Wegovy savings card can reduce costs to $25/month for eligible patients. Income restrictions apply, but it’s worth exploring if you’re paying out-of-pocket.

Frequently Asked Questions

Does Medicare cover Wegovy for weight loss?

No, Medicare does not cover Wegovy for weight loss alone due to federal restrictions on weight-loss drugs. However, if prescribed for diabetes or obesity-related conditions, coverage may be possible under Part D.

How much is the Wegovy copay with Medicare?

Copays vary by plan but typically range from $20 to $500/month. If you qualify for Extra Help, your copay could drop to $0–$10. Check your plan’s formulary for exact costs.

Can I appeal if Medicare denies Wegovy?

Yes, you can appeal through five levels of review, starting with a redetermination by your Part D plan. Success rates improve with strong clinical evidence and doctor support.

Disclaimer from HealthLeague Medical Board: This article is for informational purposes only and does not constitute medical or legal advice. Medicare coverage policies may change, and individual plan details vary. Always consult your doctor, pharmacist, or Medicare representative before making healthcare decisions.